首页> 外文期刊>Applied Microbiology >Chemotherapy of Mice Experimentally Infected with Shigella flexneri
【24h】

Chemotherapy of Mice Experimentally Infected with Shigella flexneri

机译:实验性感染弗氏志贺氏菌的小鼠的化学疗法

获取原文
       

摘要

A chronic infection with Shigella flexneri 2a has been established in mice for the evaluation of compounds for therapeutic potential. Evidence of infection is indicated by prolonged symptomless excretion in the feces and by positive isolation of organisms from different segments of the intestinal tract and from mesenteric lymph nodes. Serum antibody titer reaches a maximum after 9 days of infection and remains at a low level until 32 days postinfection. In this model, five drugs used in human shigellosis were evaluated for efficacy. Ampicillin was found to be the most active followed by oxytetracycline and kanamycin. Neomycin and colistin were the least active in this system.
机译:已经在小鼠中建立了弗氏志贺氏菌2a的慢性感染,用于评估化合物的治疗潜力。粪便中无症状的排泄时间延长,以及肠道不同部位和肠系膜淋巴结的生物体的阳性分离,表明存在感染迹象。感染9天后,血清抗体滴度达到最大值,直到感染后32天仍保持较低水平。在该模型中,评估了人类志贺菌病中使用的五种药物的功效。发现氨苄青霉素最活跃,其次是土霉素和卡那霉素。新霉素和粘菌素在该系统中活性最低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号